Showing results (81-90 of 144) with videos related to

Sort By:
Pageof 15
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|April 23, 2020
Impact of the Tumor Microenvironment on the Gene Expression Profile in Papillary Thyroid CancerMalgorzata Oczko-Wojciechowska, Aleksandra Pfeifer, Michal Jarzab, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 3, 2022
In patients with well-differentiated neuroendocrine tumours, there is no apparent benefit of somatostatin analogues after disease control by peptide receptor radionuclide therapyAleksandra Syguła, Aleksandra Ledwon, Kornelia Hasse-Lazar, et al.
Endokrynologia Polska|March 13, 2008
[Diagnostic and therapeutic guidelines for gastrointestinal neuroendocrine tumors (recommended by the Polish Network of Neuroendocrine Tumors)]Beata Kos-Kudła, Marek Bolanowski, Daria Handkiewicz-Junak, et al.
Molecular Cancer|July 1, 2014
Anterior gradient protein 2 promotes survival, migration and invasion of papillary thyroid carcinoma cellsGennaro Di Maro, Paolo Salerno, Kristian Unger, et al.
Polish Archives of Internal Medicine|March 17, 2026
TERT promoter variants in risk stratification of Polish patients with papillary thyroid carcinomaDagmara Rusinek, Aleksandra Pfeifer, Jolanta Krajewska, et al.
European Journal of Endocrinology|February 7, 2004
Follow-up of low-risk patients with differentiated thyroid carcinoma: a European perspectiveMartin Schlumberger, Gertrud Berg, Ohad Cohen, et al.
Endocrine Connections|November 29, 2019
The role of postoperative adjuvant radiotherapy in the local control in medullary thyroid carcinomaAleksandra Kukulska, Jolanta Krajewska, Zofia Kolosza, et al.
Cancer Research|March 1, 2005
Gene expression profile of papillary thyroid cancer: sources of variability and diagnostic implicationsBarbara Jarzab, Malgorzata Wiench, Krzysztof Fujarewicz, et al.
European Journal of Endocrinology|November 2, 2005
Post-surgical use of radioiodine (131I) in patients with papillary and follicular thyroid cancer and the issue of remnant ablation: a consensus reportFurio Pacini, Martin Schlumberger, Clive Harmer, et al.
Nuclear Medicine Review. Central & Eastern Europe|November 6, 2003
Simultaneous radiotherapy and radioimmunotherapy of malignant gliomas with anti-EGFR antibody labelled with iodine 125. Preliminary resultsZbigniew Wygoda, Rafał Tarnawski, Luther Brady, et al.
Pageof 15